Which has the lower trailing P/E, ABBV or MNST?

MNST has the lower trailing P/E: ABBV trades at 73.73 and MNST at 40.74. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, ABBV or MNST?

Over the past five years, MNST grew revenue faster — ABBV at a 3.69% CAGR versus MNST at 12.36%.

Does ABBV or MNST pay a bigger dividend?

ABBV pays a dividend (2.66% yield), while MNST is a former payer with no current dividend run rate.

Is ABBV or MNST more profitable?

MNST runs the higher net margin — ABBV at 9.81% versus MNST at 23.08%.

How have ABBV and MNST total returns compared?

Over the past 10 years, ABBV delivered 19.85% and MNST delivered 13.43% annualized total return. Past performance doesn't predict future results.

AbbVie Inc. (ABBV) vs Monster Beverage Corporation (MNST)

A side-by-side comparison of AbbVie Inc. and Monster Beverage Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of September 13, 2026. Differences are shown without an overall score or investment verdict.

Different business models: ABBV is classified in Healthcare; MNST is classified in Consumer Defensive. Margin, capital intensity, and valuation differences should be interpreted in that sector context.

ABBV

AbbVie Inc.

$462.37B

$261.70HealthcareDelayed quote: Sep 14, 2026, 4:00 PM EDT

MNST

Monster Beverage Corporation

$86.46B

$44.20Consumer DefensiveDelayed quote: Sep 14, 2026, 4:00 PM EDT

Total return — ABBV vs MNST

growth of $100 · dividends reinvested · last 10y

ABBV +512.1% (+19.9%/yr)MNST +238.3% (+13.0%/yr)ABBV compounded faster over this window

ABBV MNST

ABBV vs MNST: by the numbers

•ABBV is the larger company ($462.37B vs $86.46B market cap).
•MNST trades at the lower trailing earnings multiple (40.74 vs 73.73 P/E), one valuation lens rather than an overall verdict.
•MNST converts more revenue to profit (23.08% vs 9.81% net margin).
•MNST grew revenue faster over the past five years (12.36% vs 3.69% CAGR).
•ABBV pays a dividend (2.66% yield), while MNST is a former payer with no current dividend run rate.

Metrics side by side

Valuation

Metric	ABBV	MNST
P/E ratio	73.73	40.74
Forward P/E	18.63	38.09
P/S ratio	7.18	9.38
P/B ratio	N/A	9.23
EV / EBITDA	19.65	29.15
FCF yield	3.92%	2.43%

Profitability

Metric	ABBV	MNST
Gross margin	71.48%	55.55%
Operating margin	29.32%	29.16%
Net margin	9.81%	23.08%
ROE	N/A	22.72%
ROIC	13.46%	21.32%

Dividends

Metric	ABBV	MNST
Dividend yield	2.66%	N/A
Payout ratio	192.43%	N/A

Growth (annualized)

Metric	ABBV	MNST
Revenue CAGR (5Y)	3.69%	12.36%
EPS CAGR (5Y)	-2.79%	7.95%
FCF CAGR (5Y)	0.11%	7.93%
Total return CAGR (5Y)	23.70%	12.59%

Frequently asked

Which has the lower trailing P/E, ABBV or MNST?: MNST has the lower trailing P/E: ABBV trades at 73.73 and MNST at 40.74. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, ABBV or MNST?: Over the past five years, MNST grew revenue faster — ABBV at a 3.69% CAGR versus MNST at 12.36%.
Does ABBV or MNST pay a bigger dividend?: ABBV pays a dividend (2.66% yield), while MNST is a former payer with no current dividend run rate.
Is ABBV or MNST more profitable?: MNST runs the higher net margin — ABBV at 9.81% versus MNST at 23.08%.
How have ABBV and MNST total returns compared?: Over the past 10 years, ABBV delivered 19.85% and MNST delivered 13.43% annualized total return. Past performance doesn't predict future results.

Go deeper

Full ABBV analysis Full MNST analysis Interactive comparison tool

Dig into the metrics

AbbVie P/E ratio Monster Beverage P/E ratio AbbVie dividend yield AbbVie ROE Monster Beverage ROE AbbVie operating margin Monster Beverage operating margin AbbVie revenue growth Monster Beverage revenue growth AbbVie free cash flow Monster Beverage free cash flow

AbbVie & Monster Beverage appear in these rankings

Highest Dividend Yield Stocks 25+ Year Dividend Growers Highest ROIC Stocks Highest 10-Year Total Return Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified September 13, 2026.